IT1105053B - Composizione farmaceutica a base di alfa-metil-para-tirosina utile per il trattamento della schizofrenia - Google Patents

Composizione farmaceutica a base di alfa-metil-para-tirosina utile per il trattamento della schizofrenia

Info

Publication number
IT1105053B
IT1105053B IT50081/78A IT5008178A IT1105053B IT 1105053 B IT1105053 B IT 1105053B IT 50081/78 A IT50081/78 A IT 50081/78A IT 5008178 A IT5008178 A IT 5008178A IT 1105053 B IT1105053 B IT 1105053B
Authority
IT
Italy
Prior art keywords
thyrosine
schizophrenia
para
alpha
methyl
Prior art date
Application number
IT50081/78A
Other languages
English (en)
Other versions
IT7850081A0 (it
Original Assignee
Pozuelo Jose
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pozuelo Jose filed Critical Pozuelo Jose
Publication of IT7850081A0 publication Critical patent/IT7850081A0/it
Application granted granted Critical
Publication of IT1105053B publication Critical patent/IT1105053B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT50081/78A 1977-10-17 1978-06-28 Composizione farmaceutica a base di alfa-metil-para-tirosina utile per il trattamento della schizofrenia IT1105053B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/842,665 US4165382A (en) 1977-10-17 1977-10-17 Method of pharmacologically treating schizophrenia with alpha-methyl-para-tyrosine

Publications (2)

Publication Number Publication Date
IT7850081A0 IT7850081A0 (it) 1978-06-28
IT1105053B true IT1105053B (it) 1985-10-28

Family

ID=25287937

Family Applications (1)

Application Number Title Priority Date Filing Date
IT50081/78A IT1105053B (it) 1977-10-17 1978-06-28 Composizione farmaceutica a base di alfa-metil-para-tirosina utile per il trattamento della schizofrenia

Country Status (3)

Country Link
US (1) US4165382A (it)
JP (1) JPS5462325A (it)
IT (1) IT1105053B (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732915A (en) * 1983-11-02 1988-03-22 Alza Corporation Process for increasing solubility of drug
FR2647343B1 (fr) * 1989-05-24 1994-05-06 Rhone Poulenc Sante Nouvelle forme pharmaceutique poreuse et sa preparation
WO1992001667A1 (en) * 1990-07-25 1992-02-06 G.D. Searle & Co. Renal-selective prodrugs for control of renal sympathetic nerve activity in the treatment of hypertension
WO1999056747A1 (en) * 1998-05-05 1999-11-11 Jose Pozuelo Compositions and methods for treating particular chemical addictions and mental illnesses
US20040167164A1 (en) * 1998-05-05 2004-08-26 Jose Pozuelo Compositions and methods for treating particular chemical addictions and mental illnesses
US10646552B2 (en) 2012-01-17 2020-05-12 Tyme, Inc. Pharmaceutical compositions and methods
US8481498B1 (en) 2012-01-17 2013-07-09 Steven Hoffman Pharmaceutical compositions and methods
US10272068B2 (en) 2012-01-17 2019-04-30 Tyme, Inc. Pharmaceutical compositions and methods
US20130183263A1 (en) 2012-01-17 2013-07-18 Steven Hoffman Pharmaceutical compositions and methods
US10813901B2 (en) 2013-10-22 2020-10-27 Yamo Pharmaceuticals Llc Compositions and methods for treating autism
US9326962B2 (en) 2013-10-22 2016-05-03 Steven Hoffman Compositions and methods for treating intestinal hyperpermeability
US9763903B2 (en) 2013-10-22 2017-09-19 Steven Hoffman Compositions and methods for treating intestinal hyperpermeability
US9585841B2 (en) 2013-10-22 2017-03-07 Tyme, Inc. Tyrosine derivatives and compositions comprising them
US10751313B2 (en) 2013-10-22 2020-08-25 Yamo Pharmaceuticals Llc Compositions and methods for treating autism
MX2017013176A (es) * 2015-04-14 2018-01-30 Hoffman Steven Composiciones y metodos para tratar autismo.
US10426836B2 (en) * 2017-07-19 2019-10-01 Hoffman Technologies, Inc. Compositions and methods for treating stress-related disorders
JP7170722B2 (ja) * 2017-07-19 2022-11-14 ホフマン・テクノロジーズ・エルエルシー ストレス関連障害を治療するための組成物
CN112789045A (zh) * 2018-07-19 2021-05-11 亚莫制药有限公司 用于治疗孤独症的组合物和方法
WO2020018292A1 (en) * 2018-07-19 2020-01-23 Yamo Pharmaceuticals Llc Compositions and methods for treating autism
AU2020214641B2 (en) * 2019-02-01 2025-09-25 Hoffman Technologies Llc Compositions and methods for treating anxiety-related disorders
BR112021022784A2 (pt) 2019-05-14 2022-03-22 Tyme Inc Composições e métodos para tratamento do câncer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2682871A (en) * 1970-03-24 1972-09-28 Sandler Merton Pharmaceutical compositions

Also Published As

Publication number Publication date
IT7850081A0 (it) 1978-06-28
JPS5462325A (en) 1979-05-19
US4165382A (en) 1979-08-21

Similar Documents

Publication Publication Date Title
IT1105053B (it) Composizione farmaceutica a base di alfa-metil-para-tirosina utile per il trattamento della schizofrenia
IT1108440B (it) Dispositivo di illuminazione per manipoli dintistici
IT1109273B (it) Procedimento per preparare composizioni farmaceutiche a base di amossicillina
IT1093704B (it) Procedimento per la fabbricazione di etilbenzene
IT1102018B (it) Procedimento per la produzione di trimetilol-alcani
BE872319A (fr) Composition pharmaceutique
IT1109011B (it) Procedimento per la produzione di vincadifformina
IT1106615B (it) Procedimento per la produzione di solfobetaine
IT1094802B (it) Composizioni contenenti ditranol per il trattamento della psoriasi
IT1174256B (it) Procetimento per la fabbricazione di insegne
IT1095377B (it) Composizione farmaceutica
IT1105171B (it) Procedimento per la produzione di nitrosobenzolo
IT1105624B (it) Procedimento per il trattamento di fanhiglie di scarico
IT1100590B (it) Procedimento per la produzione di rifamicine
IT7849692A0 (it) Procedimento per la purificazione di urochinasi
IT1100919B (it) Agenti terapeutici a base di derivati di chinazolina
IT1157730B (it) Procedimento per la produzione di alfa-idrossimetilen-nitrili
IT1147334B (it) Composti a base di amidinouree per la cura della dismenorrea
IT7849343A0 (it) Composti analoghi di septacidina antitumore
IT1051036B (it) Procedimento per la sintesi di n metil uree
IT7868641A0 (it) Procedimento di purificazione delmercaptobenzotiazole
IT7851891A0 (it) Procedimento per la produzione di ammino-idrossi-composti aromatici
IT1102812B (it) Procedimento per la produzione di p-nitroso-difenil-idrossil-ammine
SE7806081L (sv) Basprofil for dorr
SE7813062L (sv) Farmaceutisk komposition